Matrix metalloproteinase-9 and -2 expression in the olfactory bulb following methyl bromide gas exposure

Chemical Senses

Volumn 35, Issue 8, 2010, Pages 655-661

  Bakos, Stephen R ^a   Schwob, James E ^b   Costanzo, Richard M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deafferentation; Inflammation; Matrix metalloproteinase; Methyl bromide gas; Olfactory bulb; Olfactory epithelium

Indexed keywords

GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; METHYL BROMIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEAFFERENTATION; FRONTAL CORTEX; IMMUNOHISTOCHEMISTRY; NERVE CELL DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; OLFACTORY BULB; OLFACTORY EPITHELIUM; OLFACTORY NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REINNERVATION;

ANIMALS; CENTRAL NERVOUS SYSTEM; GASES; HYDROCARBONS, BROMINATED; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OLFACTORY BULB; TIME FACTORS;

EID: 77957267587     PISSN: 0379864X     EISSN: 14643553     Source Type: Journal    
DOI: 10.1093/chemse/bjq056     Document Type: Article

References (32)

1. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. 2001. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci. 21:7724-7732.
2. Busch SA, Horn KP, Silver DJ, Silver J. 2009. Overcoming macrophagemediated axonal dieback following CNS injury. J Neurosci. 29: 9967-9976.
3. Chen X, Fang H, Schwob JE. 2004. Multipotency of purified, transplanted globose basal cells in olfactory epithelium. J Comp Neurol. 469:457-474.
4. Colín-Barenque L, Martínez-Hernández MG, Baiza-Gutman LA, Avila-Costa MR, Ordóñez-Librado JL, Bizarro-Nevares P, Rodriguez-Lara V, Piñón-Zarate G, Rojas-Lemus M, Mussali-Galante P, et al. 2008. Matrix metalloproteinases 2 and 9 in central nervous system and their modification after vanadium inhalation. J Appl Toxicol. 28:718-723.
5. Costanzo RM, Perrino LA. 2008. Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury. Neuroreport. 19:327-331.
6. Costanzo RM, Perrino LA, Kobayashi M. 2006. Response of matrix metalloproteinase-9 to olfactory nerve injury. Neuroreport. 17: 1787-1791.
7. de CRJr., Burns CL, McAdoo DJ, Romanic AM. 2000. Metalloproteinase increases in the injured rat spinal cord. Neuroreport. 11:3551-3554.
8. Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC. 2006. The cellular inflammatory response in human spinal cords after injury. Brain. 129:3249-3269.
9. Goussev S, Hsu JY, Lin Y, Tjoa T, Maida N, Werb Z, Noble-Haeusslein LJ. 2003. Differential temporal expression of matrix metalloproteinases after spinal cord injury: relationship to revascularization and wound healing. J Neurosurg. 99:188-197.
10. Gu Z, Kaul M, Yan B, Kridel SJ, Cui J, Strongin A, Smith JW, Liddington RC, Lipton SA. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 297:1186-1190.
11. Hsu JY, Bourguignon LY, Adams CM, Peyrollier K, Zhang H, Fandel T, Cun CL, Werb Z, Noble-Haeusslein LJ. 2008. Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci. 28: 13467-13477.
12. Hsu JY, McKeon R, Goussev S, Werb Z, Lee JU, Trivedi A, Noble-Haeusslein LJ. 2006. Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J Neurosci. 26:9841-9850.
13. Lee SR, Tsuji K, Lee SR, Lo EH. 2004. Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci. 24:671-678.
14. Menshikov M, Elizarova E, Plakida K, Timofeeva A, Khaspekov G, Beabealashvilli R, Bobik A, Tkachuk V. 2002. Urokinase upregulates matrix metalloproteinase-9 expression in THP-1 monocytes via gene transcription and protein synthesis. Biochem J. 367:833-839.
15. Montaner J, varez-Sabin J, Molina C, Angles A, Abilleira S, Arenillas J, Gonzalez MA, Monasterio J. 2001. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment. Stroke. 32:1759-1766.
16. Nagase H, Woessner JF Jr. 1999. Matrix metalloproteinases. J Biol Chem. 274:21491-21494.
17. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. 2002. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci. 22:7526-7535.
18. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. 1998. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke. 29:1020-1030.
19. Rosell A, Cuadrado E, Ortega-Aznar A, Hernandez-Guillamon M, Lo EH, Montaner J. 2008. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke. Stroke. 39:1121-1126.
20. Rosenberg GA. 2002. Matrix metalloproteinases in neuroinflammation. Glia. 39:279-291.
21. Rosenberg GA, Navratil M, Barone F, Feuerstein G. 1996. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab. 16:360-366.
22. Schwob JE, Youngentob SL, Mezza RC. 1995. Reconstitution of the rat olfactory epithelium after methyl bromide-induced lesion. J Comp Neurol. 359:15-37.
23. Schwob JE, Youngentob SL, Ring G, Iwema CL, Mezza R. 1999. The reinnervation of the rat olfactory bulb after methyl bromide-induced lesion of the olfactory epithelium. J Comp Neurol. 412:439-457.
24. Siebert H, Dippel N, Mader M, Weber F, Bruck W. 2001. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol. 60:85-93.
25. Silver J, Miller JH. 2004. Regeneration beyond the glial scar. Nat Rev Neurosci. 5:146-156.
26. Wang X, Jung J, Asahi M, Chwang W, Russo L, Moskowitz MA, Dixon CE, Fini ME, Lo EH. 2000. Effects of matrix metalloproteinase-9 gene knockout on morphological and motor outcomes after traumatic brain injury. J Neurosci. 20:7037-7042.
27. Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH. 2003. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 9:1313-1317.
28. Wang X, Mori T, Jung JC, Fini ME, Lo EH. 2002. Secretion of matrix metalloproteinase-2 and -9 after mechanical trauma injury in rat cortical cultures and involvement of MAP kinase. J Neurotrauma. 19:615-625.
29. Yong VW, Krekoski CA, Forsyth PA, Bell R, Edwards DR. 1998. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci. 21:75-80.
30. Yong VW, Power C, Forsyth P, Edwards DR. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci. 2:502-511.
31. Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. 2000. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 59:455-461.
32. Zuo J, Ferguson TA, Hernandez YJ, Stetler-Stevenson WG, Muir D. 1998. Neuronal matrix metalloproteinase-2 degrades and inactivates a neuriteinhibiting chondroitin sulfate proteoglycan. J Neurosci. 18:5203-5211.